ArticleInternational journal of medical sciences2025

Novel Insights into PGM2L1 as a Prognostic Biomarker in Cholangiocarcinoma: Implications for Metabolic Reprogramming and Tumor Microenvironment Modulation.

Guo-Wei Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.